| Product NDC: | 55390-480 |
| Proprietary Name: | Ketorolac Tromethamine |
| Non Proprietary Name: | Ketorolac Tromethamine |
| Active Ingredient(s): | 15 mg/mL & nbsp; Ketorolac Tromethamine |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-480 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075222 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19990426 |
| Package NDC: | 55390-480-01 |
| Package Description: | 10 VIAL in 1 BOX (55390-480-01) > 1 mL in 1 VIAL |
| NDC Code | 55390-480-01 |
| Proprietary Name | Ketorolac Tromethamine |
| Package Description | 10 VIAL in 1 BOX (55390-480-01) > 1 mL in 1 VIAL |
| Product NDC | 55390-480 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ketorolac Tromethamine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19990426 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | KETOROLAC TROMETHAMINE |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |